Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04713033 · ClinicalTrials.gov registry record

Computational Cranial and Cervical Muscle Network in Normal and Disordered Voice

A clinical trial of Dysphonia, sponsored by NYU Langone Health.

Completed
Registry status
14
Enrollment target
1
Study location

NCT04713033: Completed study of Dysphonia, sponsored by NYU Langone Health.

NCT04713033 is a study of Dysphonia that has completed, run by NYU Langone Health. The registered enrollment target is 14 participants, below the 60-participant average among 7 other Dysphonia trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04713033, a study of Dysphonia, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
14 participants
Enrollment target
1
Study location

Study Summary

The long-term goal is to transform the diagnosis and treatment of dysphonia by elucidating cervical and cranial neuromuscular mechanisms underlying typical and disordered voicing. The overall objective of this application is to propose and evaluate a novel objective spectrotemporal diagnostic tool measuring functional cervical-cranial muscle network activity in typical and disordered speakers.The purpose of this study is to improve our understanding of how the vocal tract and the muscles of the larynx and the head work at baseline and after vocal fatigue.

Primary Outcome

Both at baseline and after a vocal loading task, muscle network activity using sEMG will be measured in a variety of vocal tasks outlined above in Table 1 to explore the muscle network across different vocal demands and pitch and loudness levels. The pitch and loudness of each task produced at baseline by each participant will be calculated, and visual feedback will be provided to participants using the Real-Time Pitch module of the Computerized Speech Lab (Pentax, Montvale, NJ) to help them rep

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST surface electromyogram (sEMG)
  • DIAGNOSTIC_TEST flexible laryngoscopy

Study Locations (1)

New York

  • NYU Langone Health - New York

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2021-09-09
Est. Completion 2022-05-25
NYU Langone Health

1,164 total trials

What the finished NCT04713033 record still lists

NCT04713033 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 60-participant average among 7 other Dysphonia trials with a reported enrollment target (77% lower).

The record links to 1 condition, with Dysphonia appearing as the primary indexed condition, and to 2 interventions - of which surface electromyogram (sEMG) is the first listed.

NCT04713033 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT04713033 about?

NCT04713033 is a clinical study titled "Computational Cranial and Cervical Muscle Network in Normal and Disordered Voice". The long-term goal is to transform the diagnosis and treatment of dysphonia by elucidating cervical and cranial neuromuscular mechanisms underlying typical and disordered voicing. The overall objective of this application is to propose and evaluate a novel objective spectrotemporal diagnostic tool m...

What is the current status of trial NCT04713033?

This trial is currently completed. The enrollment target is 14 participants. The study started on 2021-09-09. Estimated completion is 2022-05-25.

What conditions does trial NCT04713033 study?

This clinical trial studies the following conditions: Dysphonia.

What interventions are being tested in trial NCT04713033?

The interventions under investigation include: surface electromyogram (sEMG) (DIAGNOSTIC_TEST), flexible laryngoscopy (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT04713033?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04713033 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dysphonia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02523092 · 14 participants · Phase 4

    Use of CXCL9 as a Biomarker of Acthar Efficacy

  • NCT04263285 · 14 participants · NA

    Treatment of Depression Post-SCI

  • NCT04743271 · 14 participants · NA

    Food and Circadian Timing

  • NCT05065671 · 14 participants · Phase 1

    Microbiome Derived Metabolism and Pharmacokinetics

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT04713033, the US trial registry maintained by the National Library of Medicine. NCT04713033 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.